Angiogenic molecular signature in colorectal cancer: Pharmacogenomic implications for the use of antiangiogenic therapies

In the framework of personalized medicine in antiangiogenesis, we took a translational research approach to explore the angiogenic molecular signature of advanced CRC patients. As derived from our findings in vitro, the tumour microenvironment of CRC metastases would be different to that of primar...

詳細記述

書誌詳細
主要な著者: Abajo, A. (Ana), Bandres, E. (Eva), Garcia-Foncillas, J. (Jesús)
フォーマット: info:eu-repo/semantics/doctoralThesis
言語:eng
出版事項: Servicio de Publicaciones de la Universidad de Navarra 2014
主題:
オンライン・アクセス:https://hdl.handle.net/10171/36697